These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38799005)

  • 1. Visnagin: A novel cardioprotective agent against anthracycline toxicity (Review).
    Obeidat O; Obeidat A; Obeidat A; Ismail MF
    Med Int (Lond); 2024; 4(4):37. PubMed ID: 38799005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity.
    Asnani A; Zheng B; Liu Y; Wang Y; Chen HH; Vohra A; Chi A; Cornella-Taracido I; Wang H; Johns DG; Sosnovik DE; Peterson RT
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics.
    Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Effects of
    Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP
    Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.
    Dallons M; Alpan E; Schepkens C; Tagliatti V; Colet JM
    Cells; 2020 Sep; 9(10):. PubMed ID: 32992522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
    Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
    Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoting mitochondrial fusion in doxorubicin-induced cardiotoxicity: a novel therapeutic target for cardioprotection.
    Maneechote C; Khuanjing T; Ongnok B; Arinno A; Prathumsap N; Chunchai T; Arunsak B; Nawara W; Chattipakorn SC; Chattipakorn N
    Clin Sci (Lond); 2022 Jun; 136(11):841-860. PubMed ID: 35543245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study on beneficial effects of vitamins B and D in attenuating doxorubicin induced cardiotoxicity in rats: Emphasis on calcium homeostasis.
    Awad HH; El-Derany MO; Mantawy EM; Michel HE; El-Naa MM; Salah El-Din RA; El-Brairy AI; El-Demerdash E
    Biomed Pharmacother; 2021 Aug; 140():111679. PubMed ID: 34029952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
    Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
    Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
    Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
    Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
    Oronsky B; Ao-Ieong ESY; Yalcin O; Carter CA; Cabrales P
    Mol Pharm; 2019 Jul; 16(7):2929-2934. PubMed ID: 31038318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling.
    Qi W; Boliang W; Xiaoxi T; Guoqiang F; Jianbo X; Gang W
    Biomed Pharmacother; 2020 Feb; 122():109547. PubMed ID: 31918264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials.
    Alharbi FK; Alshehri ZS; Alshehri FF; Alhajlah S; Khalifa HA; Dahran N; Ghonimi WAM
    Open Vet J; 2023 Dec; 13(12):1718-1728. PubMed ID: 38292716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
    Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
    Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38δ genetic ablation protects female mice from anthracycline cardiotoxicity.
    George SA; Kiss A; Obaid SN; Venegas A; Talapatra T; Wei C; Efimova T; Efimov IR
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H775-H786. PubMed ID: 32822209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective Effects of Oroxylum indicum Extract Against Doxorubicin and Cyclophosphamide-Induced Cardiotoxicity.
    Pondugula SR; Harshan A; Ramesh S; Govindarajulu M; Almaghrabi M; Majrashi M; Abbott KL; Nadar R; Alturki M; Salamat JM; Smith F; Majeed M; Nagabhushanam K; Moore T; Ren J; Dhanasekaran M
    Cardiovasc Toxicol; 2022 Jan; 22(1):67-77. PubMed ID: 34623620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.
    Stěrba M; Popelová O; Vávrová A; Jirkovský E; Kovaříková P; Geršl V; Simůnek T
    Antioxid Redox Signal; 2013 Mar; 18(8):899-929. PubMed ID: 22794198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy.
    Xia P; Liu Y; Chen J; Coates S; Liu DX; Cheng Z
    J Biol Chem; 2018 Dec; 293(51):19672-19685. PubMed ID: 30361442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-Lipoic Acid Protects Against Doxorubicin-Induced Cardiotoxicity by Regulating Pyruvate Dehydrogenase Kinase 4.
    Gong F; Jin J; Li H; Mao H
    Cardiovasc Toxicol; 2022 Nov; 22(10-11):879-891. PubMed ID: 35930219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.